Company page

Lineage Cell Therapeutics, Inc.

Lineage Cell Therapeutics, Inc. (ticker: LCTX) is a public company based in the United States, focused on developing innovative cell therapies. With a market capitalization of approximately $256.8 million, Lineage is dedicated to advancing treatments for various medical conditions through its proprietary technologies. The company aims to improve patient outcomes by leveraging its expertise in regenerative medicine.

LCTX:AMEXUpdated August 29, 2026
Lineage Cell Therapeutics, Inc. logo
Ticker
LCTX:AMEX
Asset type
Stock
Market cap
$280.7M
Sector
Health Technology
Industry
Biotechnology
Exchange
AMEX
Currency
USD